Thursday, 11 June 2020

World Ventilator-Associated Pneumonia Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

Market Scenario
According to CDC in 2013, there were 2.8 million traumatic brain injury visits to emergency department and hospitals. The emergency department visits of brain injury patients increased by 47% from 2007. Thus, increasing incidence of TBI drives the growth of the market. Furthermore, increasing geriatric population is likely to fuel the market to grow.  According to the U.S. Census Bureau in 2015, 47.8 million people were 65 years or older, and in 2060, 98.2 million are expected to be 65 years or older.  Such increasing trend in the geriatric population provides favorable backgrounds for the market to grow.
Ventilator-associated pneumonia is a type of lung infection caused to patients who are on ventilators. Ventilator-associated pneumonia is caused mainly due to lung disease, neurologic disease, and trauma to critically ill persons. Diagnosing VAP requires aggressive surveillance combined with the radiographic examination, bedside examination, and microbiologic examinations of respiratory secretions. Growing Intensive Care Unit Admissions due to rising prevalence of respiratory diseases, rising number of ICU beds and high incidence of traumatic injuries provides favorable backgrounds for the market to grow.
However, factors such as expensive diagnostic tests, high ventilator charges, inappropriate reimbursement scenario, risks associated with ventilators are expected to restrict the market growth during the forecast period.
Key players
Some of the key players contributing in the global Ventilator-associated pneumonia market share  are Merck & Co., Inc. (U.S.), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria) and other.
Segmentation
The global Ventilator-associated pneumonia market is segmented on the basis of diagnosis, mode of treatment, and end-user. The Ventilator-associated pneumonia market, by diagnosis categorized into Clinical Examination, Radiological Examination, Microbiological Analysis and others. Microbiological Analysis is further sub-segmented into Blood and pleural fluid cultures, Nonquantitative or semi-quantitative airway sampling and Quantitative cultures of airway specimens. Mode of treatment segment is segmented into Homecare, Hospital care, and others. On the basis of end-user, the market is segmented into Hospitals & Clinics, Research centers, Ambulatory Care Centers and Emergency Medical Services (EMS).      
Regional Market Summary
The Ventilator-associated pneumonia market is dominated by North America owing to the rising geriatric population within the region. The U.S. Census Bureau projected that in 2060, 19.7 million would be of age 85 or older. This influences the growth of this market in this region.
Asia Pacific was projected to be the fastest growing region for the global Ventilator-associated pneumonia market in 2017. The rising geriatric population, increasing healthcare expenditure and growing respiratory disorders in Asia is expected to drive market growth in this region. According to The Asian Development Bank (ADB), the geriatric population in Asia is estimated to reach 923 million by 2050. Thus, this provides favorable backgrounds for the Ventilator-associated pneumonia market to grow.
It is estimated that Europe stood second in the global Ventilator-associated pneumonia market owing to increasing prevalence of lung diseases. According to European respiratory society, more than 50% of deaths are due to lung diseases. Thus, increasing prevalence of lung diseases in this region influences the growth of this market in this region.
The Middle East and Africa holds the least share in the global Ventilator-associated pneumonia market due to the presence of stringent government policies, poor economies, under-developed healthcare infrastructure and low penetration of healthcare services, especially within the African region.
Posted by at No comments:

Global Enema Bags Market Expected Tremendous Growth Till 2023

Market Scenario:
Some health problems due to unhealthy eating, drinking in lifestyle may not be fatal but they can a hard time to the body they occur in. One such problem is constipation. A common remedy for constipation is an enema. Apart from constipation, enema provides relief from backaches, fatigue, and headaches. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly. A remedy helpful for many health problems always grows rapidly as a market. The factors driving the market growth include rising chronic diseases in an aging population with cancer and diabetes coupled with the increasing prevalence of gastrointestinal disorders and growing awareness about enema administration. Home care is advisable to be administered only after the advice of the clinician. Factors that can cause roadblocks to the growth of global enema bags market include the possibility of newer methods of enema treatment and environmental concerns raised from the bags that are made up of silicone, rubber, etc.
Enema is the process of injecting fluid into the bowel via the rectum. This method is used to get relief from various conditions such as constipation, fatigue, headaches, and backaches. It is a process that helps to push out the waste from the rectum. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly.
The Global Enema Bag Industry Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global enema bags market is expected to register a CAGR of ~ 10.2 % during the forecast period of 2018–2023.
Enema can be administered at hospitals as well as in home. This technique is also preferred before performing bowel procedures such as radiography and colonoscopy. The most common gastrointestinal condition affecting people nowadays is constipation with the ever-rising prevalence across the globe. Furthermore, the use of enema based products for bowel cleansing is growing extensively.
However, certain disrupting factors that might restrain the growth of enema bags include the possibility of newer methods of enema treatment. Moreover, there might be environmental issues as the bags are made up of silicone, rubber, etc.
Segmentation
The global enema bags market is segmented on the basis of the material type, product type, application, capacity, and end-user.
On the basis of material type, the market is classified into silicone, rubber, and others.
On the basis of administration type, the market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.
The global enema bags market on the basis of product type is segmented into closed or bottle enema, Higginson enema, bulb enema, bag or fountain travel enema, and others.
On the basis of indication, the market is segmented into constipation, diarrhea, obesity, cancer, and others.
On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas, and others. Barium enemas are further segmented into single-column barium enema and double-contrast barium enema.
On the basis of application, the market is segmented as bowel clearing, contrast x-ray, medication administration, and others.
On the basis of capacity, the market is segmented into 100 to 250 ml, 250 to 400 ml, 400 to 600 ml, and others.
On the basis of end-user, the global enema bags market is segmented into hospitals, clinics, research centers, and others.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American enema bags market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.
The European enema bags market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe. 
The Asia Pacific enema bags market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.
The Middle Eastern and African enema bags market is segmented into the Middle East and Africa.
Top Key Players             
The key players in global enema bags market are Baxter International, Inc. (the USA), B Braun Melsungen AG (Germany),  Cascade Healthcare Products, Inc. (the USA), Coloplast A/S (Denmark), Covidien Private Ltd. (Ireland), Farla Medical Ltd. (UK), Flexicare Medical Limited (UK), Hollister Incorporated (USA), MacoPharma (France), Medline Industries, Inc. (USA), Narang Medical Ltd. (India), Ocean Health Products Ltd. (Singapore), and Qingdao Sinoland International Trade Co., Ltd. (China).
Regional Market Summary
Globally, the American region is the largest market for enema bags owing to the high level of hygiene developed in hospitals and clinics, increasing use of enema-based products at home, and rising demand for enema kits by healthcare providers. As per a study conducted by the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. Moreover, the study stated that 20% of the North American population suffers from constipation.
Asia Pacific and North America are expected to collectively dominate the enema bags market in terms of volume and value, respectively, due to the increase in awareness towards abdominal diseases and high demand from the pharmaceutical and healthcare industry. The U.S. has the largest market of enema bags in the North American region and countries such as India and China are the highest producers of enema bags in the Asia Pacific region. The factor influencing the growth is the increasing prevalence of chronic diseases such as obesity and diabetes. Currently, the major problem in China and India is diabetes. India had the world’s second-largest population of diabetic patients that was around 69.2 million in 2015 which is expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.
The European market is growing due to the increasing prevalence of diarrhea, obesity, and constipation. Increasing cases of enema administration procedures in hospitals are contributing to the progress of the market. The prevalence of diabetes is also found to be increasing in Europe. As per a study published by the World Health Organization, almost 60 million people in the European region have diabetes, and the prevalence tends to be high among people aging 30 years and above.
The Middle East and Africa also shows a steady rise in the market owing to the availability of enema-based products, lack of physical exercise, and increasing cases of constipation.
Posted by at No comments:

Asia-Pacific Medical Suction Device Market Staggering Double Digit Cagr Till 2023

Asia-Pacific Medical Suction Device Market - Highlights
MRFR is the Leading Brand in The Research Company who Recently Published Asia-Pacific Medical Suction Device Market Research Report. The Medical Suction Device is basically fitted into hospital for the many medical reasons. A Medical Suction machine is device used for the respiratory conditions. The Asia-Pacific market of Medical Suction Device s is expected to grow with a CAGR of 7% during the forecasted period 2017-2023.
The Respiratory conditions like generally results into secretion of mucous, serum that has to be removed for the body. The device is used to remove serum or mucous when the patient is not able to secrete it out from the body. Also, the suction machines are used for several other reasons for example, while operative procedures, delivery of baby.
The Asia-Pacific market of Medical Suction Device Market is growing because of the rising prevalence of diabetes which requires the insulin suction devices, whereas the increasing pollution in the countries are creating the demand for respiratory suction devices.
The medical suction device is basically fitted into hospital for the many medical reasons. A medical suction machine is device used for the respiratory conditions. The respiratory conditions like generally results into secretion of mucous, serum that has to be removed for the body. The device is used to remove serum or mucous when the patient is not able to secrete it out from the body. Also the suction machines are used for several other reasons for example, while operative procedures, delivery of baby. The suction machine utilizes a long catheter to vacuum out the blocking secretions. The secreted material is collected into a jar and then emptied after the process is done. The suction machine work on the power/electric supply or on the battery power. The power required for the machine is 110volts. Batteries of this volts are also available so that the patients can use the device when there is no power supply. The cleaning and replacement of the parts of the machine is very necessary as the machine is used for the patient. So as to maintain the cleanliness the suction machines are cleaned after every use. The cleaning of the machine parts are easy. The machine also has a bacterial filters that are also replaceable and can be replaced very month.
The Asia-Pacific market of Medical Suction Device is growing because of the rising prevalence of diabetes which requires the insulin suction devices, whereas the increasing pollution in the countries are creating the demand for respiratory suction devices. The Asia-Pacific market of Medical Suction Device s is expected to grow with a CAGR of 7% during the forecasted period 2017-2023.
Asia-Pacific Medical Suction Device Market - Key Players
Some of the major players in this market are: De Vilbiss Healthcare, Fluke Biomedical, Yang Zhou Huike Electronic, Allied Healthcare Products. Inc, Olympus Corporation, Gemmy Industrial Corp., Ohio Medical, ATMOS Medizin Tchnik, INTEGRA biosciences, Medicop Inc. and others
Asia-Pacific Medical Suction Device Market - Study Objectives
  • To provide detailed study of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Medical Suction Device market.
  • To provide insights about factors affecting the market growth.
  • To analyze the Medical Suction Device market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies of Asia-Pacific, and countries in this region like, Japan, China, India, Republic of Korea, Rest of Asia and Pacific.
Asia-Pacific Medical Suction Device Market - Segments
Asia-Pacific Medical Suction Device market has been segmented on the basis of types which comprises of types, usage and suctions parts. On the basis of types there are two major types movable and electrical suction device. On the basis of the usage airway suctioning, gastrointestinal decompression, pleural suctioning, operative suctioning and others. On the basis of the suction parts vacuum pumps, bacterial filter, vacuum gauge, moisture or debris trap, suction catheter and others.
Asia-Pacific Medical Suction Device Market - Regional Analysis
Asia-Pacific region is divided into two major regions, Asia and Pacific. Further Asia is divided into the Countries like Japan, China, India, Republic of Korea, and Rest of Asia. The Asia-Pacific market for Medical Suction Device is estimated to grow at a rapid pace during the forecasted period 2017-2023. This is due to increasing number in the technology adoption for the medical devices and the homecare devices. The large number of the respiratory suction devices are in great demand. Countries like China and India have increasing number of chronic respiratory diseases. The increasing number of diabetes in India have a great demand for the insulin suction devices.

Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Continued….
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Posted by at No comments:

Worldwide Acromegaly Market 2019 Synopsis With Leading Players, Industry Growth Factor Foresight By 2023

The major driving factors for the market are increasing prevalence of acromegaly, changing lifestyle, and increasing genetic incident of genetic diseases. Moreover, increasing prevalence of hormonal diseases, for instance, endocrine diseases, and hypopituitarism, increasing government support and rapid developments in technology have fuelled the growth of the market. On the other hand, surgical costs is high, which ranges from approximately USD 2,800 to USD 9,200, however, when averaged it is less than the cost of medications. Unavailability of precise treatment and high cost of the surgery may restrain the growth of the market.
The global acromegaly treatment market growth is expected to boost at a CAGR of ~5.2 % during the forecast period 2017-2023.
Acromegaly is a hormonal disorder that results from heavy secretion of growth hormones (GH) in the body. The pituitary gland in the brain, secretes GH. In acromegaly, the pituitary produces excessive amounts of GH. Usually the excess GH comes from benign, or noncancerous, tumors on the pituitary. These benign tumors are called adenomas. Acromegaly is one of the rare diseases, which most often diagnosed in the middle-aged adults and affects 5-8 people per 1 lakh people. If the diseases is not treated, it can result in serious illness and premature death. The most serious health consequences of the disease may result into high blood pressure, type 2 diabetes, increased risk of cardiovascular disease, arthritis, and others.
Key Players
  • Novartis AG (Switzerland),
  • Aegis Therapeutics LLC (US),
  • Chiasma Inc (US),
  • Crinetics Pharmaceuticals Inc (US),
  • Daewoong Pharmaceutical Co Ltd (South Korea),
  • Peptron Inc (South Korea),
  • Silence Therapeutics Plc (UK),
  • Strongbridge Biopharma plc (US),
  • Amryt Pharma plc (UK),
  • Foresee Pharmaceuticals LLC (US),
  • Glide Pharmaceutical Technologies Ltd (US),
  • Ionis Pharmaceuticals Inc (US),
  • Ipsen SA (France)
Segmentation
Acromegaly market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of treatment, the market is segmented into medications, surgery, radiation therapy, and others. The medication is further segmented into somatostatin analogues, dopamine agonists, growth hormone receptor antagonists, and others. The surgery is further segmented into endonasal transphenoidal surgery, and transphenoidal surgery.
On the basis of diagnosis, the market is segmented into medical imaging, medical laboratory investigations, others. The medical imaging is further segmented into radiography, magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and others.
On the basis of type, the market is segmented into ectopic acromegaly, acromegaly due to growth hormone, and others.
Regional Analysis
Asia Pacific is the fastest growing acromegaly market. China, and India are the significant contributors to the market growth due to the presence of huge population base, increasing prevalence of acromegaly, rapidly growing healthcare sector, and increasing healthcare expenditure. Whereas, the Middle East & Africa holds the least Acromegaly Market share of the global market due to poor economic condition and limited availability of medical facilities in African region. The Middle East & African acromegaly market is majorly driven by the UAE, Saudi Arabia, and Kuwait.
The Americas commands the global market owing to increasing prevalence of acromegaly, large patient population, high healthcare spending, and strong government support for research & development. According to the Health Research Funding Organization, in America, over 3,000 new cases of acromegaly occurs per year.
Europe leads the second position of the global the market, which is followed by Asia Pacific. High healthcare expenditure, well developed healthcare sector, and increasing government support drives the growth of the market.
Posted by at No comments:

Ear Infection Treatment Market Forecasts By Industry Drivers, Regions Till 2023

Market Scenario
An ear infection is invasion of the ear tissue by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute affecting for a short duration but chronic ear infections can cause permanent damage to the middle and inner ear.
Infants younger than 6 months have higher chances of infection accompanied by a fever higher than 102°F and severe ear pain. According to the healthline, middle ear infections occur in 80 % of children by the time they reach age three. Swimmer’s ear is a common outer ear infection affecting approximately 0.4 million healthcare visits annually in the United States.
The Global Ear Infection Treatment Market is expected to reach USD 22.3 Billion by 2023, and the market is projected to grow at a CAGR of Approx 6.6 % during the forecast period 2017-2023.
The developments in the surgery segment, such as minimal invasive laparoscopy surgery, is driving the global ear infection treatment market growth. The drug segment is, however, suffering from market fragmentation, which has put pressure on the price margins. The loss of patents and the rise of counterfeited drugs has also restricted the market growth. The other market constrains are high cost of surgery and complications of the surgery. Market development represents the best strategy for the market growth. The market is expected to witness exponential growth over the review period owing to minimal invasive surgical procedures.
Product development represents the best strategy for dominating the market as surgery is the definitive treatment for high ear infection treatment market. The advent of minimally invasive treatment and diagnostic techniques such as computed tomography has changed the market landscape to a large extent. Miniaturization of surgical instruments and development of minimal invasive treatment such as robotic laparoscopy is expected to drive the future market in the developed regions of North America and Europe. Cost of the product will be a decisive factor in the developing regions such as Asia Pacific and especially Africa. The growing demand for better and minimally invasive surgical procedures is the greatest unmet need of the market.
Ear Infection Treatment Industry Segments:
The global ear infection treatment market has been segmented on the basis of type, pathogen diagnosis, treatment, and end user.
Based on the type, the market has been segmented as outer ear, middle ear, inner ear.
Based on the diagnosis, the market has been segmented as hearing test, microbial test, otoscopy and tympanometry, Computerized Tomography (CT), other.
Based on the treatment, the market has been segmented as surgery, drugs, and others.
Based on the pathogen, the market has been segmented as bacteria, virus and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.
The market drivers for global ear infection treatment market are rise in risk factors, increasing awareness regarding the severity of untreated ear infection, development of healthcare, technological development in diagnostic devices and surgery segment especially the advancements in minimally invasive surgery etc. The market restraints are the complications of surgery, high cost of treatment, emergence of bacterial resistance, etc.
Key Players in the Global Ear Infection Treatment Market:
  • American Diagnostic Corporation
  • Pfizer plc.
  • Heine USA Ltd.
  • Welch Allyn
  • TorquePharma
  • Medtronic
  • Intersect ENT, Inc.
  • Olympus Corporation
  • Grace Medical
  • American Diagnostic Corporation.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions, and poor healthcare development.
Posted by at No comments:

International Bronchoscopes Market 2019 Estimation And Forecasts Up To 2023

Market Scenario
Bronchoscopy has become an essential part of modern medicine. The examination by bronchoscopy has become the most common method to diagnose any kind of abnormality in the normal function of the respiratory system. Bronchoscopes are the instruments used for visualizing the insides of the patient’s airways. Bronchoscopes are usually inserted through nose or mouth, and occasionally through the trachea. Owing to the recent advances in medicine, a number of bronchoscopes have been introduced. Flexible bronchoscopes have been introduced to diagnose the diseases in trachea and the bronchi. Due to their different advantages, they are widely accepted throughout various countries and regions. The global bronchoscope industry is majorly driven by increasing prevalence of respiratory tract diseases for instant, lung cancer and COPD, increasing number of bronchoscopies procedures, and increasing preference for minimally invasive procedures.
According to the WHO (World Health Organization), in 2015, 64 million people have chronic obstructive pulmonary disease (COPD), whereas, over 3 million people died of COPD. Additionally 1.8 million people across the globe were suffering from lung cancer. Increasing number of healthcare organization and patient inflow have boosted the number of bronchoscopy procedures. Moreover, increasing geriatric population, increasing healthcare expenditure, and changing environmental condition have fuelled the growth of the market over the review period. However, high cost of the devices and risk of infection may slow the growth of the market.
The bronchoscopes market share is growing at a healthy pace. The market is expected to grow at the CAGR of 7.4% during the forecast period and is estimated to reach USD 2,244.4 million by 2023.
Segmentation                                                                                                                                      
The global bronchoscopes market is segmented on the basis of types, application, and end users.
On the basis of types, the market is segmented into rigid bronchoscopes, and flexible bronchoscopes. Flexible bronchoscopes are further sub-segmented into fiber optic bronchoscopes, and video bronchoscopes.
On the basis of application, the market is segmented into diagnosis, and surgical procedure. Diagnosis is further segmented into examination, patient’s airways, bleeding lungs, possibility of lung cancer, chronic cough, and obtain tissue specimen for biopsy. Surgical procedure is further segmented into removal of a foreign object in the airway, laser resection of tumors, lung abscess, stent insertion, percutaneous tracheostomy, and tracheal intubation.
On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers and others.
Regional Analysis                     
Considering the global scenario of the market, America dominates the global bronchoscopes market owing to the presence of huge patient population, high healthcare spending and well developed healthcare sector.
North America holds the largest market share in the American bronchoscopes market. According to the Centers for Medicare & Medicaid Services, in 2015, U.S. healthcare spending increased 5.8% during last few years. Additionally, increasing government support for research & development have fueled the market growth of the American bronchoscopes market. Europe has the second largest market for the bronchoscopes which is followed by Asia Pacific. Due to the presence of a well-developed healthcare sector, increasing prevalence of respiratory diseases and high healthcare spending, the bronchoscopes market in Europe is growing at a CAGR of 6.9%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness about the availability of the treatment, increasing patient inflow, huge population base, and rising healthcare expenditure. The Middle East & Africa is expected to have limited growth. Middle East is dominating this market by holding major share of the Middle East & Africa market owing to the well developed technology and healthcare sector.
Key Findings:
  • Flexible bronchoscopes segment accounts for the largest market share in the global bronchoscopes market and is expected to be the fastest growing market with the CAGR of 8.0 % during the forecast period.
  • Diagnosis commanded the largest market share in 2016 and was valued at USD 885.7 million in 2016 and is expected to reach at USD 1,484.2 million by 2023.
  • On the basis of end users, Hospitals & clinics segment accounts for the largest market share of 49.1% in the global bronchoscopes market.
  • The Americas bronchoscopes market is expected to reach USD 868.7 million by 2023, at a CAGR of 7.4 % during the forecast period.
Key Players for Global Bronchoscopes Market
Some of the major players in this market are: Ambu Inc. (US), Boston Scientific Corporation (US), Cogentix Medical (US), Fujifilm Holdings Corporation (Japan), Olympus Corporation (Japan), Pentax Medicals (Japan), and KARL STORZ GmbH & Co. KG (Germany), Schindler Endoskopie Technologie Gmbh (Germany), Schölly Fiberoptic Gmbh (Germany), Vimex Sp. (Poland), Hangzhou EndoTop Medi-Tech Co., Ltd.(China), Guangzhou MeCan Medical Limited (China), and LocaMed (UK).
Posted by at No comments:

Acute Care Electronic Health Recorder (EHR) Market 2023 – Market Size, Share, Trends Analysis And Growth Forecast

Acute care EHR is different from its traditional counterparts. The acute care EHR allows healthcare professionals to collect, preserve and access vital patient clinical data in acute care and ambulatory care settings. Market Research Future (MRFR) perceives the global acute care EHR market to register a CAGR of 7% over the forecast period of 2017-2023.

The global acute care EHR market growth driven by the surging incidences of chronic diseases on a global scale. In recent years, the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease have been on the rise which has consequently raised the number of healthcare institutions. Growth in a number of hospitals and other medical centers have created massive demand for management of patient data which boosts the growth of the global acute care EHR market. The rise in global geriatric population is also a contributing factor to the growth of the global acute care EHR market. The aged population who are more susceptible to suffer from chronic diseases have induced high demand for remote monitoring of geriatric patient data. Factors such as development in healthcare IT, technological advancements and expanding expenditure on healthcare act as a plus for the growth of the market. On the contrary, the growth of the global acute care EHR market might be restrained by high costs associated with acute care EHR solutions which might limit the growth of the market in price-sensitive market. Furthermore, towering costs of healthcare devices and treatments are also likely to hinder market growth.


Competitive Landscape
The noteworthy players in the global acute care EHR market include Epic Systems Corporation (U.S.), Evident (CPSI) (U.S.), eClinicalWorks (U.S.), Medhost (U.S.), Athenahealth (RazorInsights) (U.S.), IBM (U.S.), Vitera Healthcare Solutions (U.S.), Meditech (U.S.), McKesson Corporation (U.S.), Allscript (U.S.), Cerner Corporation (Siemens) (U.S.), Healthland (U.S.), and General Electric Company (U.S.).

Segmentation
The global acute care EHR market has been segmented based on deployment, application, and end user.

By deployment, the global acute care EHR market has been segmented into On-Premises based and Web-based.

By application, the global acute care EHR market has been segmented into personal care, pharmaceuticals, and others.

By end user, the global acute care EHR market has been segmented into hospital, ambulatory care, and others.

Regional Analysis
The Americas dominate the global acute care EHR market owing to the increasing number of hospitals ambulatory centers, presence of huge patient population and well developed technology. The hospital and clinics are able to afford the cost of the devices as these are funded by several sources: the public sector, charities, health insurance companies, health organizations of all kinds, etc. Additionally, the people in this region are able to afford high cost of treatment on account of higher per capita income in this region. Rapidly increasing patient population, governments have started supporting the manufacturers for the development of new and better devices which has driven the growth of the market. Moreover, well developed technology, high healthcare expenditure, and huge geriatric population have fuelled the growth of the market in this region.
Asia Pacific is the fastest growing acute care EHR market owing to the increasing number of patients suffering from chronic diseases and rapidly increasing number of hospitals & clinics. Additionally, rapidly growing economies and increasing healthcare expenditure will fuel the growth of the market. On the other hand, the Middle East & Africa hold the least share of the market owing to less availability of funds, limited availability of medical facilities, and poor political conditions in Africa.
Europe commands the second largest market for acute care EHR which is followed by Asia Pacific. Availability of funds, strong government support, and increasing need for the better management devices & platform drive the growth of the market in Europe. Western Europe holds a major share of the market due to the presence of well developed economies. U.K, Germany and France are the major contributors of the market.
Industry Updates
  • In November 2018, ResMed, a company that specializes in connected devices and remote monitoring for sleep apnea and respiratory illnesses announced the acquisition of MatrixCare’s post-acute care EHR solution for USD 750 million.

  • In December 2018, Allscripts, a provider of healthcare solutions, announced selling of its stake in post-acute care EHR vendor Netsmart to TA Associates and GI Partners, both private equity firms for a total amount of USD 525 million.
Posted by at No comments:
Subscribe to: Posts (Atom)